# Effect of Single vs Repeated Cycles of a Combination of Granulocyte Colony Stimulating Factor and Darbepoetin vs Standard Medical Treatment on Immunometabolic Profile in Patient With Early Decompensated Cirrhosis.

> **NCT07002827** · NA · NOT_YET_RECRUITING · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 60 (estimated)

## Conditions studied

- Decompensated Liver Cirrhosis

## Interventions

- **DRUG:** Darbepoetin
- **DRUG:** G-CSF
- **DRUG:** Lactulose
- **BIOLOGICAL:** Albumin

## Key facts

- **NCT ID:** NCT07002827
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-30
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-04-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07002827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07002827, "Effect of Single vs Repeated Cycles of a Combination of Granulocyte Colony Stimulating Factor and Darbepoetin vs Standard Medical Treatment on Immunometabolic Profile in Patient With Early Decompensated Cirrhosis.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07002827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*